Skip Nav Destination
Issues
1 April 2009
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Hypothesis/Commentary
Human Biospecimen Research: Experimental Protocol and Quality Control Tools
Fotini Betsou; Rebecca Barnes; Thomas Burke; Domenico Coppola; Yvonne DeSouza; James Eliason; Barbara Glazer; David Horsfall; Cynthia Kleeberger; Sylvain Lehmann; Anil Prasad; Amy Skubitz; Stella Somiari; Elaine Gunter; [International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science]
Review
Research Articles
Global DNA Hypomethylation (LINE-1) in the Normal Colon and Lifestyle Characteristics and Dietary and Genetic Factors
Jane C. Figueiredo; Maria V. Grau; Kristin Wallace; A. Joan Levine; Lanlan Shen; Randala Hamdan; Xinli Chen; Robert S. Bresalier; Gail McKeown-Eyssen; Robert W. Haile; John A. Baron; Jean-Pierre J. Issa
Serum Retinol and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Jeannette M. Schenk; Elio Riboli; Nilanjan Chatterjee; Michael F. Leitzmann; Jiyoung Ahn; Demetrius Albanes; Douglas J. Reding; Yinghui Wang; Marlin D. Friesen; Richard B. Hayes; Ulrike Peters
Risk of Non–Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development
Lindsay M. Morton; Mark P. Purdue; Tongzhang Zheng; Sophia S. Wang; Bruce Armstrong; Yawei Zhang; Idan Menashe; Nilanjan Chatterjee; Scott Davis; Qing Lan; Claire M. Vajdic; Richard K. Severson; Theodore R. Holford; Anne Kricker; James R. Cerhan; Brian Leaderer; Andrew Grulich; Meredith Yeager; Wendy Cozen; Shelia Hoar Zahm; Stephen J. Chanock; Nathaniel Rothman; Patricia Hartge
Null Results in Brief
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.